Neurosurgical Oncology Department, Humanitas Cancer Center and Research Hospital, Via Manzoni, 56 20089, Rozzano (Milan), Italy.
Radiotherapy and Radiosurgery Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy.
J Neurooncol. 2017 Oct;135(1):129-139. doi: 10.1007/s11060-017-2559-9. Epub 2017 Jul 8.
The extent of surgical resection (EOR) has been recorded as conditioning outcome in glioblastoma multiforme (GBM) patients but no significant improvements were recorded in survival. The study aimed to evaluate the impact of EOR on survival, investigating the role of fluid-attenuated inversion recovery (FLAIR) abnormalities removal. 282 newly diagnosed GBM patients were treated with surgery followed by concurrent and adjuvant chemo-radiotherapy. The EOR was defined as: SUPr, in case of resection amounting to 100% of enhanced and FLAIR areas; gross total (GTR) in case of resection between 90 and 100% of enhanced areas with variable amount of FLAIR abnormalities; sub-total (STR), between 10 and 89%; biopsy (B) <10%. FLAIR-RTV was dichotomized in percentage values to identify the best separation threshold for progression free survival (PFS) and overall survival (OS). SUPr was obtained in 21 patients (7.4%), GTR in 60 (21.3%), STR in 143 (50.7%) and biopsy only in 58 (20.6%). The median, 1, 2-year PFS were 10.4 ± 0.4 months, 39.0 ± 3.0, and 17.0 ± 2.0%; the median, 1, 2-year OS were 14.5 ± 0.5 months, 63.3 ± 3.0, and 23.1 ± 3.1%. EOR was significantly influencing survival (p < 0.001). The median, 1, 2-year OS were 28.6 ± 5.2 months, 90.0 ± 6.0, 71.0 ± 10.0% for patients underwent SUPr vs. 16.2 ± 1.2 months, 81.0 ± 5.0, 24.0 ± 6.0% for GTR. The FLAIR removal threshold conditioning survival was 45%. Minor complications were recorded in 14 (5%) patients and major in 8 (2.8%). surgical resection beyond contrast-enhancing boundaries could represent a promising strategy to improve outcome in GBM patients. The identification of a FLAIR-RTV threshold can be useful in clinical practice and it was recorded as factor influencing survival.
手术切除范围(EOR)已被记录为胶质母细胞瘤(GBM)患者的预后因素,但在生存方面没有显著改善。本研究旨在评估 EOR 对生存的影响,研究了清除液体衰减反转恢复(FLAIR)异常的作用。282 名新诊断的 GBM 患者接受手术治疗,随后进行同步和辅助放化疗。EOR 的定义如下:SUPr,如果切除量达到增强和 FLAIR 区域的 100%;如果切除量在增强区域的 90%至 100%之间,伴有不同程度的 FLAIR 异常,则为大体全切除(GTR);如果切除量在 10%至 89%之间,则为次全切除(STR);如果切除量<10%,则为活检(B)。将 FLAIR-RTV 分为百分比值,以确定无进展生存期(PFS)和总生存期(OS)的最佳分离阈值。21 名患者(7.4%)获得 SUPr,60 名患者(21.3%)获得 GTR,143 名患者(50.7%)获得 STR,58 名患者(20.6%)仅获得活检。中位、1 年和 2 年 PFS 分别为 10.4±0.4 个月、39.0±3.0 和 17.0±2.0%;中位、1 年和 2 年 OS 分别为 14.5±0.5 个月、63.3±3.0 和 23.1±3.1%。EOR 显著影响生存(p<0.001)。SUPr 组患者的中位、1 年和 2 年 OS 分别为 28.6±5.2 个月、90.0±6.0 和 71.0±10.0%,GTR 组患者的中位、1 年和 2 年 OS 分别为 16.2±1.2 个月、81.0±5.0 和 24.0±6.0%。FLAIR 切除范围的生存条件为 45%。14 名(5%)患者出现轻微并发症,8 名(2.8%)患者出现严重并发症。超越对比增强边界的手术切除可能是改善 GBM 患者预后的一种有前途的策略。确定 FLAIR-RTV 阈值在临床实践中可能是有用的,它被记录为影响生存的因素。